RhumbLine Advisers’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.4K | Sell |
512
-50
| -9% | -$4.73K | ﹤0.01% | 3671 |
|
|
2025
Q1 | $35.7K | Sell |
562
-388
| -41% | -$24.6K | ﹤0.01% | 3645 |
|
|
2024
Q4 | $44.1K | Sell |
950
-8
| -0.8% | -$371 | ﹤0.01% | 3670 |
|
|
2024
Q3 | $27.6K | Buy |
958
+117
| +14% | +$3.37K | ﹤0.01% | 3776 |
|
|
2024
Q2 | $12.2K | Buy |
841
+343
| +69% | +$4.96K | ﹤0.01% | 3950 |
|
|
2024
Q1 | $8.01K | Buy |
498
+221
| +80% | +$3.55K | ﹤0.01% | 3907 |
|
|
2023
Q4 | $5.5K | Buy |
277
+79
| +40% | +$1.57K | ﹤0.01% | 3963 |
|
|
2023
Q3 | $3.23K | Buy |
198
+45
| +29% | +$733 | ﹤0.01% | 4046 |
|
|
2023
Q2 | $3.23K | Buy |
+153
| New | +$3.23K | ﹤0.01% | 4152 |
|